Navigation Links
An international competition reaffirms the potential of bioinformatics in the diagnosis of disease
Date:11/26/2012

The biosciences are generating enormous amounts of data at unprecedented speeds. Making sense of these data and extracting useful and reliable information from databases is an increasingly difficult and complex task. Backed by the scientific community, IBM Research y Philip Morris International (PMI) R&D launched a project called IMPROVER (Industrial Methodology for PROcess VErification in Research) in May with the aim of challenging the world's best computational researchers to demonstrate the power of their methods to exploit genomic information to extract predictive and clinical indicators that are reliable and verifiable.

The first challenge posed by IMPROVER, "Diagnosis Signature", consisted of classifying a group of patients for four diseases by using genomic data obtained from clinical samples in so-called "blind tests". The team led by IRB Barcelona and Anaxomics Biotech achieved fourth place worldwide, in the competition that saw the participation of 54 groups, mainly from Europe and the US. The project was announced in Nature Biotechnology and the results from the competition will be published in high impact journals.

According to David Rossell, head of the Biostatistics and Bioinformatics Unit at IRB Barcelona who designed the probability prediction algorithms, "this type of international challenge is very effective as a proof of concept, to demonstrate that it is possible to make predictions and to make them well, when the world's most advanced and effective techniques are used." Patrick Aloy, Group Leader at the join IRB Barcelona-BSC program in computational biology, who specializes in molecular networks in disease added: "This competition fosters the creation of a scientific body of evidence for the biomedical community, including both researchers and clinicians, that adds value to and instills confidence in biocomputational techniques and their industrial applications.

Using biological information in statistical algorithms

The challenge consisted of using computational methods to evaluate and verify samples from patients with psoriasis, multiple sclerosis, chronic pulmonary obstruction and lung cancer. The IRB Barcelona team's method was two-fold: first, Anaxomics Biotech provided published information on proteins involved in each of the diseases, and Dr. Aloy expanded this biological documentation with unpublished data from other molecules that are known to be involved. Second, Dr. Rossell integrated the biological information into his probability prediction tools. "It's a question of separating the wheat from the chaff: we need to identify which subgroups of the thousands of genes we are dealing with are important in order to use them in our analysis. We need to combine our knowledge taken from databases with data we get from experiments to get the best results," explains Rossell.

The first IMPROVER challenge has highlighted the predictive power of biocomputation given that the majority of participants were able to diagnose patients with at least 90% certainty, and in some cases 100%.

The organizers plan to continue the IMPROVER project for the next four years. They have already announced the second challenge, which will be launched in 2013.


'/>"/>

Contact: Snia Armengou
armengou@irbbarcelona.org
34-934-037-255
Institute for Research in Biomedicine (IRB Barcelona)
Source:Eurekalert

Related biology news :

1. Ultracold matter technology from CU and SRI International licensed to Boulders ColdQuanta
2. International Polar Year conference: From knowledge to action
3. Large international study finds memory in adults impacted by versions of 4 genes
4. International team uncovers new genes that shape brain size, intelligence
5. Southampton researchers lead 2 international projects to help people out of poverty
6. UCSD researchers: Where international climate policy has failed, grassroots efforts can succeed
7. Washington University receives $8 million to lead international childhood malnutrition effort
8. Early Bird Discounts Available on International Healthcare and Biotechnology Conferences, Save Up To $600 with Global Information
9. New HealthFocus® International Study Reveals Five Very Different Weight Management Consumers
10. OU scientists and international team deciper the genetic code of the tomato
11. Digicel Launches Worlds First Biometric Identification System For International Money Transfers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, ... developing therapeutics focused on the gut microbiome, today ... of 25,000,000 shares of its common stock and ... stock at a price to the public of ... to Synthetic Biologics from the offering, excluding the ...
(Date:6/27/2016)... 27, 2016 Research and Markets has announced ... report to their offering. ... to grow at a CAGR of 12.28% during the ... on an in-depth market analysis with inputs from industry experts. The ... coming years. The report also includes a discussion of the key ...
(Date:6/21/2016)... British Columbia , June 21, 2016 /PRNewswire/ ... appointed to the new role of principal product ... been named the director of customer development. Both ... NuData,s chief technical officer. The moves reflect NuData,s ... teams in response to high customer demand and ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... , Dec 5, 2016 Research and ... "Biomarkers - Technologies, Markets and Companies" to their offering. ... , , ... their discovery using various -omics technologies such as proteomics and metabolomics. ... new tests are also based on biomarker. Currently the ...
(Date:12/5/2016)... 2016 /PRNewswire/ - Resverlogix Corp. ("Resverlogix" or the ... and Safety Monitoring Board (DSMB) for the Company,s ... (CVD) patients has completed a second planned safety ... as planned without any modifications. The DSMB reviewed ... or efficacy concerns were identified. The DSMB will ...
(Date:12/4/2016)... ... December 02, 2016 , ... A proposed five-year extension ... federally funded research and development is welcome news for the photonics community, say ... , As part of the National Defense Authorization Act (NDAA) compromise agreement finalized ...
(Date:12/2/2016)... 2016 More than $4.3 million was raised last ... DHMD ). The gala was held at the American Museum ... and honored Alan Alda and ... and medicine and the public understanding of science. Since the ... event has raised $40 million for the Laboratory,s research and ...
Breaking Biology Technology: